482P - Tislelizumab exposure-response analyses of efficacy and safety in patients with advanced tumors
| Autor: | Wu, C.-Y., Budha, N., Gao, Y., Castro, H., Nkobena, A., Ben, Y., Sahasranaman, S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v182-v183 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|